QNTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quantum Biopharma Ltd (QNTM) is not a good buy for a beginner investor with a long-term strategy right now. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts to drive growth. Additionally, there are no strong trading signals or significant insider/hedge fund activity to support a buy decision.
The stock exhibits bearish technical indicators: MACD is negative and contracting, RSI is oversold at 16.314, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The pre-market price is down 1.24%, and the stock is trading near support levels (S1: 3.714, S2: 3.399).
NULL identified.
A class action lawsuit has been filed against CIBC and RBC for allegedly manipulating Quantum Biopharma's stock prices. Weak financial performance and bearish technical indicators further weigh on the stock.
In Q3 2025, the company reported a net income of -$5,319,029, which improved 32.47% YoY but remains negative. EPS dropped significantly by -67.96% YoY to -1.4. Revenue and gross margin remain at 0, reflecting no meaningful growth.
No analyst rating or price target changes are available for this stock.
